ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,104.01
0.08%
US Tech 100
17,301.60
0.36%
Dow Jones
38,305.65
0.17%
Brent Oil
87.17
-0.58%
Bitcoin
62,817.19
-0.29%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kyverna Therapeutics Inc (KYTX) Quote

Kyverna Therapeutics Inc

Kyverna Therapeutics Inc (KYTX)

NASDAQ
14.945
-0.525
( -3.39% )
Updated: 14:23:04
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
14.945
Bid
14.92
Ask
14.97
Volume
667,176
13.96 Day's Range 15.80
13.96 52 Week Range 35.01
Market Cap
610.297M
Previous Close
15.47
Open
15.70
Last Trade
100
@
14.945
Last Trade Time
14:23:04
Financial Volume
$ 9,654,782
VWAP
14.4711
Average Volume (3m)
429,684
Shares Outstanding
40,822,525
Dividend Yield
-
PE Ratio
-10.11
Earnings Per Share (EPS)
-1.48
Revenue
-
Net Profit
-60.37M

About Kyverna Therapeutics Inc

Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
kyvernatx.com
Headquarters
Dover, Delaware, USA
Founded
1970
Kyverna Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYTX. The last closing price for Kyverna Therapeutics was $15.47. Over the last year, Kyverna Therapeutics shares have traded in a share price range of $ 13.96 to $ 35.01.

Kyverna Therapeutics currently has 40,822,525 shares outstanding. The market capitalization of Kyverna Therapeutics is $610.30 million. Kyverna Therapeutics has a price to earnings ratio (PE ratio) of -10.11.

KYTX Latest News

More News

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune...

April 11 2024
PR Newswire (US)

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med PR Newswire EMERYVILLE, Calif., March 29, 2024 Two patients were treated...

March 29 2024
PR Newswire (US)

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results PR Newswire EMERYVILLE, Calif., March 26, 2024 Advanced clinical development in two broad areas of...

March 26 2024
PR Newswire (US)

Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis

Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis PR Newswire EMERYVILLE, Calif., March 7, 2024 The...

March 07 2024
PR Newswire (US)

Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire EMERYVILLE, Calif., Feb. 12, 2024 EMERYVILLE...

February 12 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.235-17.794279427918.1819.6713.9638466116.70732807CS
4-9.705-39.371196754624.6525.8413.9641697720.58278007CS
12-19.305-56.364963503634.2535.0113.9642968425.44333994CS
26-19.305-56.364963503634.2535.0113.9642968425.44333994CS
52-19.305-56.364963503634.2535.0113.9642968425.44333994CS
156-19.305-56.364963503634.2535.0113.9642968425.44333994CS
260-19.305-56.364963503634.2535.0113.9642968425.44333994CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.698501
(79.10%)
148.19M
DCPHDeciphera Pharmaceuticals Inc
$ 25.205
(72.05%)
43.44M
HWHHWH International Inc
$ 2.72
(49.45%)
28.89M
MULNMullen Automotive Inc
$ 4.7101
(49.05%)
50.43M
SINTSiNtx Technologies Inc
$ 0.0556
(37.62%)
153.13M
CLVRClever Leaves Holdings Inc
$ 1.6901
(-58.88%)
686.13k
ADXNAddex Therapeutics Ltd
$ 8.1164
(-49.59%)
140.49k
MFImF International Ltd
$ 1.598
(-31.42%)
2.75M
TSDDGraniteShares ETF Trust GraniteShares
$ 17.7024
(-28.91%)
1.33M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 27.93
(-28.88%)
6.89M
TSLATesla Inc
$ 192.6565
(14.48%)
197.19M
SINTSiNtx Technologies Inc
$ 0.0556
(37.62%)
153.13M
CAUDCollective Audience Inc
$ 0.698501
(79.10%)
148.19M
SOFISoFi Technologies Inc
$ 7.07
(-10.17%)
124.82M
NKLANikola Corporation
$ 0.653
(1.49%)
73.97M

Discussion

View Full Feed
Gwinner Gwinner 2 minutes ago
doesn't look like any bid support either this is might end up being my biggest tax loss if I decide to dump...
ZIVO
ruke ruke 3 minutes ago
You can better stop posting right now! If Q1/2024 is bad we are heading to $1.50. If Q1 is good then $4 is a possibility.
PLUG
VeronicaFox VeronicaFox 3 minutes ago
I see you slipped in “Confessions of a Paid Basher”, one of the biggest internet hoaxes. It is not only a hoax that dates all the way back to November, 2000 it was revealed to be a hoax almost immediately and has since become perhaps the most celebrated hoax in internet history.

An
KEGS
Papa Grizz Papa Grizz 3 minutes ago
Howdy LilLu, hope u r doing well. Just a Floki drive by. See Ya
FLOKIUSD
PRmaniac PRmaniac 3 minutes ago
It is worse than that - assets can be seized
HPNN has so many liens and the court-entered documents indicate any present or future assets the CEO or HPNN have or ever obtain are subject to seizure.
Ask the loser Peter Michaels why he can't own a car, home, or any property.
Ask h
HPNN
CommonCents3 CommonCents3 3 minutes ago
Thank you. That is definitely positive news. Thought he was throwing in the towel.

Now find a merger partner, Hsu!!!!

CC3
NLSC
Genz2 Genz2 3 minutes ago
https://www.zdnet.com/article/yikes-microsoft-copilot-failed-every-single-one-of-my-coding-tests/
TradeSmart.ai TradeSmart.ai 3 minutes ago
Been adding all I can, I can smell it here :-) $ILST
ILST
irishintelligence irishintelligence 3 minutes ago
I knew a guy one time who knew a guy and they did this thing.

Your posts are so sad.
SPZI
getmoreshares getmoreshares 3 minutes ago
bid? my l2 is not loading
BLFR
Thehubby Thehubby 3 minutes ago
Are we up today because of the ANVS results?
ANVS
IGUESSHEWONT IGUESSHEWONT 4 minutes ago
Thanks Mike..Let's hope the new administration acts upon its words and doesn't give a speach every morning. Some of the members of the "Energy Sector" are tired of hearing him speak.
MRGE
Goldnuget Goldnuget 4 minutes ago
What other ventures do he have do he have?
GCAN
OncoJock OncoJock 4 minutes ago
Thank you for sharing this information with us.

-- OJ
HALO
Vettelover98 Vettelover98 4 minutes ago
Yes! My thought is we have trials coming up. Wait till then. We will definitely see a run closer to court dates
VPLM
surfkast surfkast 4 minutes ago
Exchange Act Registered - A periodic report for a fiscal period end within the last 180 calendar days from the end of the issuer’s most recent fiscal year or any quarterly reporting period that is covered by a report required by Section 13 or 15(d) of the Exchange Act.


UNITED
NHMD
MightyX MightyX 4 minutes ago
Required over 4x avg volume to drop 10% without reaching new lows..looks like analyst/short seller pump n dump
SOFI
Jimmy Joe Jimmy Joe 4 minutes ago
Hope u can get more

Me too Darrdarr. We'll see. If I can't I ride with what I have.
TPTW
ExtremelyBullishZig ExtremelyBullishZig 5 minutes ago
You are supposed to sell when that happens...not buy.
AVXL
Agoura Guy Agoura Guy 5 minutes ago
WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!

NICE DROP!!!!!!!!!!!!


https://i1.wp.com/themindshield.com/wp-content/uploads/2021/02/9442056_010721-cc-GettyImages-qanon-shaman-img.jpg?fit=1536%2C864&ssl=1
SPY
$treet Trader $treet Trader 5 minutes ago
on EM there is no bid or ask
CIVX
SSP SSP 5 minutes ago
Well you in now, and those calls should be winners for us.
ATOM
janice shell janice shell 5 minutes ago
We used to have Waldorf salad all the time when I was a kid. I never much cared for it.
monocle monocle 5 minutes ago
Within a penny of the floor, does anyone know how Yorkville gets paid with the price drops below $2.14?
NB
Express1 Express1 5 minutes ago
Karma soon for the person who trashed a recovering alcoholic, who is trying to lead a normal life. Then we have this idiot making fun of the person. Karma wins, losers lose. Maybe you will learn after Karma, maybe should not have made fun of the shareholder. Never screw with Karma. You will los
BOMO

Your Recent History

NASDAQ
KYTX
Kyverna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved